Proven Antimicrobial Medical Technology
bio–ARMA®, LLC. has developed innovative solutions for comprehensive treatment and protection in the areas of medical devices and wound care, infection control, and health & wellness.
bio-ARMA™ uses our novel bio-based antimicrobial compound embedded directly into our materials to create products highly resistant to the growth of harmful bacteria, viruses and fungus.
SCIENCE
bio-ARMA™ uses a bio-based solution, novel in its composition, and non-toxic. Through extensive testing bio-ARMA™ products have proven to fall into a decreasing class of broad spectrum antimicrobials, that not only eliminate most gram-positive and gram-negative bacteria, but also mold, fungi, viruses, etc.
PRODUCTS
In cooperation with selected manufacturing partners, bio-ARMA™ produces high-value medical-grade antimicrobial medical products for hospitals and the health-care industry, as well as a line of consumer products for home and work place first aid and care. From bandages and materials, to specialized equipment.
MATERIALS
bio-ARMA™ also offers our antimicrobial additive to branded product manufacturing partners, in cost effective and tested concentrations for a wide range of materials. From paper and plastic to nanofiber, liquids and adhesives, our additive offers protection against the most serious anti-biotic resistant bacteria, viruses and fungi.
A Growing Bacterial Resistance
Bacterial infections, the growth of mold and fungi are typically subjects which cause people concern. Due to an overuse and misuse of antibiotics over the years, antibiotic resistance grows, the antibiotics used to treat infections do not work as well or at all. The loss of effective antibiotic treatments will not only cripple the ability to fight routine infectious diseases but will also undermine treatment of infectious complications in patients with other diseases.
Many of the advances in medical treatment—joint replacements, organ transplants, cancer therapy, and treatment of chronic diseases such as diabetes, asthma, rheumatoid arthritis—are dependent on the ability to fight infections with antibiotics. If that ability is lost, the ability to safely offer people many life-saving and life-improving modern medical advantages will be lost with it.
The next 20 years will see a significant growth our world’s elderly population. This segment requires the greatest number of operations, typically lives in shared accommodation, have weaker immune systems and are generally more susceptible to hospital acquired infections (HAI’s). The demand for quality antimicrobial medical products is poised to grow significantly.
Proven Results
bio-ARMA™ products have been proven to eliminate most bacteria, mold, fungi and superbugs
(bacteria resistant to most forms of antibiotics) including:
CRE
(Carbapenem-resistant Enterobacteriaceae)
MRSA
(methicillin resistant Staphylococcus aureus)
VRE
(vancomycin resistant Enterococcus)
A Serious and Expensive Problem
Today, The Infectious Disease Society of America estimates that the annual cost to the U.S. healthcare system of infections caused by antibiotic-resistant bacteria is $21 billion to $34 billion, including 8 million additional hospital days. Seventy years after the beginning of the “antibiotic era,” there is an acute and growing public health need for new treatments to address infections caused by MDR bacteria.
The threat of bacterial resistance is growing exponentially. Bacteria grows on a multitude of surfaces and is easily passed by human contact.
Minimizing bacterial migration can only be eliminated by a two part program:
- Building antimicrobial resistance into materials, so that residual bacteria left on the surface before or after cleaning doesn’t multiply and is eliminated.
- Disinfecting all surfaces with antimicrobial cleaners.
Together, antimicrobial medical products and effective infection control can play a major role in reducing the threat of antimicrobial resistance.
Recent Industry News
Surfaces near patients with C. auris commonly re-contaminated within hours of cleaning
Room surfaces near patients colonized with Candida auris were commonly re-contaminated within hours of cleaning or disinfection Date: April 20, 2022 Source: Healio Author: Caitlyn Stulpin Excerpt: "They collected samples from participants’ body sites and the surfaces around them before their rooms were cleaned and disinfected, followed by the [...]
Genomic sequencing reveals MRSA spread within, between ICUs
Whole-genome sequencing revealed the spread of MRSA strains among patients, health care workers and the environment, including within — and even between — ICUs, according to findings in Clinical Infectious Diseases. Date: June 15, 2020 Source: Healio.com Author: Caitlyn Stulpin Excerpt: “For pathogens such as MRSA, hospitals may choose [...]
Regions with early interest, adoption of face masks showed modest COVID-19 infection rates
Countries with early interest in face mask use had milder COVID-19 infection rates Date: June 25, 2020 Source: Healio.com Author: Erin T. Welsh, MA Excerpt: "Researchers with the Chinese University of Hong Kong reported findings from an analysis of how public interest in face masks, based on Google Trends [...]